Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$62.55 USD
-3.63 (-5.49%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $62.51 -0.04 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Hims & Hers Health, Inc. has a market cap of $14.81B, which represents its share price of $66.18 multiplied by its outstanding shares number of 223.83M. As a large-cap company, HIMS's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HIMS 62.55 -3.63(-5.49%)
Will HIMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Other News for HIMS
HIMS Stock Faces Mixed Sentiment Ahead of Earnings Report
Option traders moderately bearish in Hims and Hers Health with shares down 5.67%
Hims & Hers Health Inc (HIMS) Faces Class Action Lawsuit Over Alleged Misconduct | HIMS ...
Hims & Hers Health Earnings Preview
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?